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Background: Highly purified nuclear protein is required when using an electrophoretic mobility shift assay (EMSA)
to study transcription factors, e.g. nuclear factor-κB (NF-κB), a major transcription factor that regulates both innate
and adaptive immune responses following infection. Although many protocols have been developed for nuclear
protein extraction, they are not necessarily optimized for use in EMSA, often require a large number of cells and
long processing times, and do not always result in complete separation of the nuclear and cytoplasmic fractions.
Results: We have developed a simple, rapid and cost-effective method to prepare highly purified nuclear proteins
from a small number of both suspended and adherent cultured cells that yields nuclear proteins comparable to
those prepared by a standard large-scale method. The efficiency of the method was demonstrated by using EMSA
to show the successful detection, in multilple concurrent samples, of NF-κB activation upon tetradecanoyl phorbol
acetate (TPA) stimulation.
Conclusions: This method requires only a small number of cells and no specialized equipment. The steps have
been simplified, resulting in a short processing time, which allows researchers to process multiple samples
simultaneously and quickly. This method is especially optimized for use in EMSA, and may be useful for other
applications that include proteomic analysis.
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Infection and subsequent initiation of the innate immune
response result in a rapid secretion of inflammatory cyto-
kines through activation of various transcription factors.
Among those transcription factors, nuclear factor-κB (NF-
κB), which usually exists as a heterodimer formed between
subunits p50 and RelA/p65, plays a central role in both
innate and adaptive immune responses [1-3]. In unstimu-
lated cells, NF-κB exists in the cytoplasm as an inactive
form sequestered by the inhibitor protein IκB [4]. Upon
stimulation by a variety of stimuli, including bacterial lipo-
polysaccharide (LPS) [5], tumor necrosis factor α (TNF-α)
[6], interleukin-1β (IL-1β) [7] and reactive oxygen species* Correspondence: koichis@nih.go.jp
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unless otherwise stated.(ROS) [8], IκB is degraded by IκB kinase (IKK), thus
unmasking nuclear localization signals (NLS) that allow
NF-κB to enter the nucleus, where it orchestrates the
transcription of specific genes [9].
The electrophoretic mobility shift assay (EMSA), a
common affinity electrophoresis technique used to study
protein-nucleic acid interactions, is often employed to
demonstrate the binding of the active form of nuclear
NF-κB to its DNA recognition sequence at several time
points following a particular stimulation. The first and
possibly the most crucial step in ensuring accurate
detection of NF-κB binding and stoichiometry by EMSA
is purification of nuclear protein extracts that contain
DNA-binding proteins with no contamination by the
cytoplasmic fraction.
Many basic protocols for the extraction of whole nu-
clear protein, and modified protocols to further separateis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Efficient release of nuclei from cells using hypo-osmotic
buffer and pipetting. Phase-contrast microscopic image of THP-1
cells in Lysis Buffer before (A) and after (B) pipetting through a 200-μl
pipette tip. Original magnification: ×200. Arrowheads indicate membrane
components around the nuclei that were observed before (A), but not
after (B), pipetting.
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olar proteins, and histone proteins), have been published
in the 70 years since subcellular fractionation was intro-
duced [10-22]. Today, a wide range of commercial prod-
ucts, although much more costly, are available for more
convenient application of subcellular fractionation, and a
number of procedures have been optimized for use in
proteomic studies [14,23-25]. Indeed, nuclear protein
extraction procedures should be optimized for starting
material (cultured cells or tissues), scale (numbers of cells
and samples), downstream applications and available time
and cost. However, we noted several drawbacks when
using previously reported procedures. They were laborious
and time-consuming, required large (15 ml) centrifuge
tubes, and necessitated a large number of cells. In re-
sponse, we developed a novel EMSA protocol that allows
examination of the binding and stoichiometry of nuclear
NF-κB in a small quantity of cultured cells (e.g. cells from
one well in a 6-well plate).
We describe here a new small-scale method that can
yield ready-to-use high-purity nuclear proteins optimized
for use in EMSA. It is rapid and cost-effective, allowing
the simultaneous and rapid processing of multiple samples
in the same batch experiment. The method is highly
efficient, as demonstrated by the simultaneous detection
of NF-κB activation and binding in multiple samples of
THP-1 human monocyte cells and FRTL-5 rat thyroid
epithelial cells upon stimulation of tetradecanoyl phorbol
acetate (TPA).
Results and discussion
New homogenization method for small-scale preparation
of nuclear extracts
The basic principle underlying subcellular fractionation
procedures is that each cellular organelle or component
(e.g. cytoplasm and nucleus) has a distinct molecular
composition, size, shape, density, and solubility. The first
step in preparing nuclear proteins is to gently break
open, or homogenize, the cells, enabling separation of
the cytoplasm and nucleus. Homogenization can be
achieved by osmotic shock, mechanical force, sonication,
or combinations of these techniques. We modified previ-
ously reported methods [15,26] and developed a new
homogenization protocol that can be used with a small
quantity of cells (5×105 cells). In this modified proced-
ure, collected cells are resuspended in a hypo-osmotic
lysis buffer, while 2% Tween-40 (a non-denaturing non-
ionic detergent) solubilizes and disrupts cytoplasmic
membranes. However, hypo-osmotic lysis buffer alone is
often insufficient to ensure full release of nuclei from
cells, which, in our experience, is the most important
step for avoiding contamination by cytosolic proteins. As
shown in Figure 1A, human monocytic leukemia THP-1
cells suspended in the hypo-osmotic lysis buffer stillhave membrane components (arrowheads) around the
nuclei, indicating a need for mechanical force.
Mechanical force to rupture cells is most often achieved
using the glass Dounce homogenizer [15,22,24,27-30];
however, such specialized equipment is not suitable for a
small-scale method. During preliminary experiments, we
found that pipetting cells in hypo-osmotic lysis buffer
through a conventional 200-μl pipette tip 60–200 times is
sufficient to completely release nuclei and yield high-
purity nuclear protein in cultured hematopoietic, fibro-
blasts and epithelial cell lines. Nuclear protein yields may
depend on the number of passes: drawing lysate through
the pipette tip 100 times gave satisfactory results in all cell
lines tested in our preliminary experiments. Microscopic
observation is used to determine whether nuclei are com-
pletely released from cells and ready for separation from
the cytoplasmic fraction (Figure 1B).
Optimizing separation of nuclear and cytoplasmic fractions
Two types of centrifugation are usually used for fraction-
ation: differential centrifugation and sucrose density gradi-
ent centrifugation. It is believed that differential centri
fugation yields crude fractions, while purer fractions are
obtained from density gradient centrifugation. A sucrose
density gradient solution is prepared by overlaying sucrose
solutions (at different concentrations) in order of their
densities (concentrations) in a centrifuge tube, with the
heaviest solution at the bottom. Samples placed on top of
the solution will travel down the gradient during centrifuga-
tion until reaching a sucrose solution of matching density.
Thus, density gradient centrifugation allows further separ-
ation of cellular components according to their densities
and minimizes cross-contamination. To minimize contam-
ination by the cytoplasmic fraction, we incorporated
sucrose density gradient centrifugation into this procedure
using an isotonic 0.3-1.5 M sucrose density gradient. The
intermediate phase between 0.3 M and 1.5 M sucrose
Figure 2 Nuclear protein extracts contain active NF-κB
heterodimers. Non-adherent monocytic THP-1 cells were
stimulated by TPA at the indicated concentrations for 30 minutes.
Nuclear proteins were subsequently purified from THP-1 cells and
EMSA was performed using an NF-κB-specific DNA probe (lanes
1–3). For specific competition experiments, unlabeled excess
(125-fold molar) probe was pre-added to the proteins (lane 4).
Figure 3 Nuclear protein extracts are comparable to those
prepared by a standard large-scale method. Adherent rat thyroid
FRTL-5 cells were stimulated by 50 nM TPA for 30 minutes. Nuclear
proteins were subsequently purified using the new small-scale
method (lanes 1 and 2) or an established large-scale method [15]
(lanes 3 and 4). Whole cellular protein was also isolated [37] from
TPA-treated cells to illustrate the presence of the cytoplasmic form
of NF-κB (lane 5). EMSA was performed using an NF-κB-specific
DNA probe.
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pure nuclei extracts are pelleted to the bottom of the tube.
Washing nuclei pellets in low-salt wash buffer after sucrose
density gradient centrifugation also minimizes contamin-
ation from the cytoplasmic fraction.
High salt extraction is an efficient method for small-scale
nuclear protein extraction
In large-scale methods, tip sonication is often applied to
extract the nuclear proteins after nuclei extracts are ob-
tained [22,27,30,31]. In a small-scale procedure, high-salt
extraction is more practical [23,25]. During this step,
nuclei incubated in a high-salt extraction buffer will shrink
and nucleic acid-binding proteins, including transcription
factors, will be extracted through the nuclear pores and
solubilized in the extraction buffer [15]. Following cen-
trifugation, the supernatant (less than 50 μl) contains
high-concentration high-purity nuclear proteins. Since
this procedure generates a high concentration of nuclear
proteins, a small volume of protein can be added directly
to the EMSA reaction mixture without a laborious dialysis
step to remove salts.
Validation of the new small-scale nuclear protein extraction
method
Nuclear proteins prepared using this method were used
to evaluate the activated form of nuclear NF-κB in THP-
1 cells treated with increasing concentrations of TPA, a
drug that can induce cell activation, proliferation and
cytokine production via stimulation of the NF-κB tran-
scription factor [1,32-36]. THP-1 cells were stimulated
with TPA for 30 minutes before nuclear protein was iso-
lated and used in EMSA. As shown in Figure 2, levels of
the active form of NF-κB increased with increasing con-
centrations of TPA (Figure 2 lanes 1–3). When an ex-
cess amount of unlabeled probe was added, the band
representing the protein-DNA complex was eliminated
(Figure 2, lane 4), indicating that the visualized band
was indeed formed by NF-κB, not by non-specific
protein-DNA binding.
We then tested this method using adherent epithelial
cells, from which nuclei release appeared to be more
difficult than in hematopoietic THP-1 cells. FRTL-5
cells stimulated by 5 nM TPA for 30 minutes were
scraped from a 6-well cell culture plate and pelleted in
1.5-ml microcentrifuge tubes. Nuclear proteins were
then purified using our newly developed small-scale
method. For comparison, nuclear proteins were also
prepared using a standard large-scale method for highly
purified nuclear protein extraction that requires at least
1×109 cells and homogenization using a Dounce glass
homogenizer [15]. Whole cell proteins containing both
active and inactive forms of NF-κB were also prepared
using a method described previously [37]. EMSAdetection of NF-κB clearly illustrated that the quality of
nuclear proteins purified using the present method
(Figure 3, lanes 1 and 2) is comparable to that of pro-
teins prepared by the previous large-scale method [15]
(Figure 3, lanes 3 and 4) with no contaminating cyto-
plasmic fractions, which is clearly visible in EMSA
using whole cell proteins (Figure 3, lane 5).
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tion after TPA stimulation in two cell types, showing that
this simplified small-scale extraction of nuclear proteins is
highly effective for downstream EMSA applications.
Conclusions
We have developed a simplified method of obtaining
high-purity nuclear protein for use in EMSA. The method
uses significantly fewer cultured cells than current con-
ventional methods (up to 4 logs less). Key procedures are
disruption of the plasma membrane by pipetting cells
through a conventional 200-μl pipette tip in a hypo-osmic
solution containing detergent, separation of nuclei by
sucrose density gradient centrifugation, and high-salt
extraction of nuclear proteins. Multiple samples can be
processed simultaneously as all the procedures are per-
formed in a conventional 1.5-ml microcentrifuge tube.
Using this method, nuclear proteins can be prepared in a
short time from both suspended and adherent cultured
cells, which may be compatible with use in proteomic
assays as well.
Methods
Cell culture and TPA stimulation
THP-1, a human monocytic leukemia cell line, was ob-
tained from the American Type Culture Collection (ATCC;
Manassas, VA) and cultured in RPMI medium supple-
mented with 10% charcoal-treated fetal bovine serum, 2%
nonessential amino acids, and 50 mg/ml penicillin/strepto-
mycin as described [38,39]. Rat thyroid FRTL-5 cells pro-
vided by Interthyr Research Foundation (Athens, OH) were
maintained in Coon’s modified Ham’s F-12 medium supple-
mented with 5% bovine serum (Invitrogen, Carlsbad, CA)
and a six-hormone mixture as previously described [40,41].
For TPA stimulation, culture medium was replaced, 30 mi-
nutes before nuclear protein was extracted, with the same
medium containing 5 nM or 50 nM of TPA.
Nuclear protein extraction
Reagents
Dithiothreitol (DTT) (Sigma cat. No. D0632)
Dulbecco’s modified phosphate buffered saline (DPBS)
(Sigma cat. No. D1283)
Ethylenediaminetetraacetic acid (EDTA) (Sigma cat.
No. EDS)
Glycerol (Sigma cat. No. G5516)
HEPES (Sigma cat. No. H3375)
Leupeptin (Sigma cat. No. L2884)
Magnesium chloride (MgCl2) (Sigma cat. No. M8266)
Potassium chloride (KCl) (Sigma cat. No. P9333)
Potassium hydroxide (KOH) (Sigma cat. No. P5958)
Phenylmethanesulfonyl fluoride (PMSF)
(Sigma cat. No. P7626)Pepstatin A (Sigma cat. No. P5318)
Protease inhibitor cocktail tablets (Roche cat.
No. 11697498001)
Sodium chloride (NaCl) (Sigma cat. No. S7653)
Sucrose (Sigma cat. No. S7903)
Tween-40 (Sigma cat. No. P1504)
Solutions
Low-salt wash buffer: 10 mM HEPES-KOH pH 7.9,
10 mM KCl, 1.5 mM MgCl2, 0.1 mM EDTA, 0.5 mM
DTT, 0.5 mM PMSF, 2 ng/ml pepstatin A, and 2 ng/ml
leupeptin.
Hypo-osmotic lysis buffer: 0.3 M sucrose, 2% (v/v)
Tween 40, 10 mM HEPES-KOH pH 7.9, 10 mM KCl,
1.5 mM MgCl2, 0.1 mM EDTA, 0.5 mM DTT, 0.5 mM
PMSF, 2 ng/ml pepstatin A, and 2 ng/ml leupeptin.
1.5 M sucrose buffer: 1.5 M sucrose, 10 mM HEPES-
KOH pH 7.9, 10 mM KCl, 1.5 mMMgCl2, 0.1 mM EDTA,
0.5 mM DTT, 0.5 mM PMSF, 2 ng/ml pepstatin A, and
2 ng/ml leupeptin.
High-salt extraction buffer: 20 mM HEPES-KOH
pH 7.9, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA,
25% glycerol, 0.5 mM DTT, 0.5 mM PMSF, 2 ng/ml pep-
statin A, and 2 ng/ml leupeptin.
Protease inhibitors including DTT, PMSF, pepstatin A,
and leupeptin were added immediately prior to use. On
occasion, a protease inhibitor cocktail tablet (Roche) was
used instead. Hypo-osmotic lysis buffer and 1.5 M sucrose
buffer were prepared by adding sucrose and Tween-40 or
sucrose to low-salt wash buffer at the indicated
concentrations.
Equipment
Table-top Microcentrifuge (Eppendrof 5415D)
Inverted routine microscope (Nikon Eclipse TS100)





In the following procedure, all samples, reagents and tubes
were pre-chilled and kept on ice. All centrifugations were
performed in a table-top microcentrifuge at 12,000 rpm
and 4°C. Typically, 5×105 cells were collected and pelleted
by centrifugation for 30 seconds in a 1.5-ml microcentri-
fuge tube. The supernatants were removed and the cell
pellets were resuspended and washed in 1 ml of ice-cold
Dulbecco’s modified phosphate buffered saline (DPBS).
After another centrifugation, pellet, packed cell volume
(pcv) was estimated, and the pellets were resuspended in a
volume of hypo-osmotic lysis buffer 5 times the pcv. At
this point, samples can be stored at −80°C until needed
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mogenized by pipetting 100 times using a micropipette
with a 200-μl pipette tip. Enucleated samples were over-
laid on 1 ml of 1.5 M sucrose buffer and centrifuged for
10 minutes. Purity of the nuclei and distribution of other
cellular components before and after sucrose density gradi-
ent centrifugation were checked by examinating a small ali-
quot of sample under a phase contrast microscope.
Supernatants were removed after centrifugation and the
nuclear pellets were resuspended in 1 ml of low-salt wash
buffer and pelleted again by centrifugation for 30 seconds.
After the supernatants were removed, the washed nuclear
pellets (retained as cleaner nuclei) were resuspended in
50 μl of high-salt extraction buffer and placed on ice for
20 minutes with occasional vortexing. Following 20 minutes
of extraction, the samples were centrifuged for 20 minutes
and the supernatants were retained as high-purity nuclear
proteins.
Determination of protein concentration
Protein concentration was determined using DC protein
assay reagents (BIO-RAD, CA) according to the manu-
facturer’s instructions [40,41]. Specific absorbance at
750 nm was measured using a VMax Kinetic Microplate
Reader (Molecular Devices, Sunnyvale, CA).
EMSA
EMSA was performed with the DIG Gel Shift Kit, 2nd
Generation (Roche, Basel, Switzerland) according to the
manufacturer’s instructions. Briefly, a double-stranded
DNA probe specific for NF-κB responsive element (5′-
AGTTGAGGGGACTTTCCCAGGC-3′) was labeled with
digoxigenin-11-ddUTP. Nuclear protein samples (0.2 μg)
were mixed with 0.4 ng of labeled DNA probe. For the
competition assay, 125-fold molar excess unlabeled DNA
probe was premixed with the protein for 20 minutes before
labeled DNA probe was added. The mixture was electro-
phoresed on a 6% (v/v) non-denaturing polyacrylamide gel
in 0.5x Tris-boric acid-electrophoresis (TBE) buffer at 4°C.
Following electrophoresis, protein was transferred from the
gel to a positively charged nylon membrane by electroblot-
ting. Digoxigenin-labeled complexes on the membrane
were detected using an alkaline phosphatase-conjugated
anti-digoxigenin antibody (1:10,000) and its chemilumines-
cent substrate disodium 3-(4-methoxyspiro {1,2-dioxetane-
3,2′-(5′-chloro) tricyclo [3.3.1.13,7]decan}-4-yl)phenyl phos-
phate (CSPD), both provided in the kit. Chemiluminescent
signals were visualized by exposing the membranes to X-ray
film.
All reagents were purchased from Sigma-Aldrich
(St. Louis, MO) unless otherwise indicated.
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